ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons

Journal of the American College of Cardiology (Impact Factor: 16.5). 06/2008; 51(21):e1-62. DOI: 10.1016/j.jacc.2008.02.032
Source: PubMed
Download full-text


Available from: David P Faxon,
  • Source
    • "In our case, there was no clinical or laboratory evidence of maternal or fetal autoimmune disease. The 2008 guidelines of the American Heart Association, the American College of Cardiology Foundation, and the Heart Rhythm Society recommend that a permanent pacemaker be implanted in patients with congenital complete AV block with no delay (15). However, there are several problems with doing this in neonates and young infants. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Congenital myotonic dystrophy (CMD) is an inherited neuromuscular disorder with cardiac rhythm abnormalities that may occur as a child grows. No report has described complete atrioventricular (AV) block detected in a neonate with CMD. We report a floppy infant of 31+4 weeks gestation with complete AV block at birth, who was diagnosed with CMD by Southern analysis. She recovered from complete AV block 32 hr after temporary transcutaneous pacing was applied. To the best our knowledge, this is the first recorded case of a complete AV block accompanied by CMD during the neonatal period. When a newborn has a complete AV block, the physician should consider the possibility of the CMD and conduct a careful physical examination. Graphical Abstract
    Journal of Korean Medical Science 06/2014; 29(6):879-83. DOI:10.3346/jkms.2014.29.6.879 · 1.27 Impact Factor
  • Source
    • "To our knowledge, no data is available regarding mortality in patients on RRT with permanent pacemakers (PM) [10– 12]. These groups of patients are not included in the current guidelines [13] [14]. Mortality rates are likely to be higher due to the advanced age, the high incidence of stroke, and comorbidities. "
    [Show abstract] [Hide abstract]
    ABSTRACT: End stage renal disease is a relatively frequent disease with high mortality due to cardiac causes. Permanent pacemaker (PM) implantation rates are also very common; thus combination of both conditions is not unusual. We hypothesized that patients with chronic kidney disease with a PM would have significantly higher mortality rates compared with end stage renal disease patients without PM. Our objectives were to analyze mortality of patients on renal replacement therapy with PM. 2778 patients were on renal replacement therapy (RRT) and 110 had a PM implanted during the study period. To reduce the confounding effects of covariates, a propensity-matched score was performed. 52 PM patients and 208 non-PM matched patients were compared. 41% of the PM were implanted before entering the RRT program and 59% while on RRT. Mortality was higher in the PM group. Cardiovascular disease and infections were the most frequent causes of death. Propensity analysis showed no differences in long-term mortality between groups. We concluded that in patients on RRT and PM mortality rates are higher. Survival curves did not differ from a RRT propensity-matched group. We concluded that the presence of a PM is not an independent mortality risk factor in RRT patients.
    International Journal of Nephrology 05/2014; 2014(2014):1-8. DOI:10.1155/2014/284172
  • Source
    • "This could be explained by the preferential epicardial infiltration of the disease. Indications of ICD for primary prevention of SCD in ARVC/D patients have not been well established [3] [7] "

    International journal of cardiology 04/2014; 174(1). DOI:10.1016/j.ijcard.2014.03.180 · 4.04 Impact Factor
Show more